DAFTAR PUSTAKA
American Academy of Neurology (1995) Determining brain death in adult.Neurology 45:1012- 1014.
Anderson J.P (2006) Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease. J Biol Chem281: 29739- 52
Ardley H.C., Robinson P.A. (2005) E3 ubiquitin ligases. Essays Biochem41:15-30. Babetto E., Beirowski B., Janeckova L., Brown R., Gilley J., Thomson D.,
Ribchester R.R., Coleman M.P. (2010) Targeting NMNAT1 to axons and synapses transforms its neuroprotective potency invivo. J Neurosci 30:13291-13304
Baker R.T., Board P.G. (1987) The human ubiquitin gene family: structure of a gene and pseudogenes from the Ub B subfamily. Nucleic Acids Res15: 443-63.
Beirowski B., Adalbert R., Wagner D., Grumme D.S., Addicks K., Ribchester R.R., Coleman M.P. (2005) The progressive nature of Wallerian degeneration in wild-type and slow Wallerian degeneration (WldS) nerves. BMC Neurosci 6:6
Berger F., Lau C., Dahlmann M., Ziegler M. (2005) Subcellular compart- mentation and differential catalytic properties of the three human nicotinamide mononucleotide adenylyltransferase isoforms.J Biol Chem 280:36334–36341
Berger R.P., Pierce M.C., Wisniewski S.R., Adelson P.D., Clark R.S., Ruppel R.A., Kochanek P.M. (2002) Neuron- specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children. Pediatrics 109:E31.
Bendlin B.B., Ries M.L., Lazar M., Alexander A.L., Dempsey R.J., Rowley H.A., Sherman J.E., Johnson S.C. (2008) Longitudinal changes in patients with traumatic brain injury assessed with diffusion-tensor and volumetric imaging. Neuroimage, 42: 503-514.
Bener A., Omar A.O., Ahmad E., Al-Mulla F.H., Abdul Rahman Y.S. (2010) The pattern of traumatic brain injuries: a country undergoing rapid development. Brain Inj 24:74-80
Berger R.P., Beers S.R., Richichi R., Wiesman D., Adelson P.D. (2007) Serum biomarker concentrations and outcome after pediatric traumatic brain injury. J Neurotrauma 24: 1793-1801.
Bigler E.D., Maxwell W.L. (2011) Neuroimaging and neuropathology of TBI.NeuroRehabilitation 28: 63-74.
Blyth B.J., Farahvar A., He H., Nayak A., Yang C., Shaw G. (2011) Elevated Serum Ubiquitin Carboxy-Terminal Hydrolase L1 is Associated with Abnormal Blood Brain-Barrier Function after Traumatic Brain Injury. J of Neurotr 28:2453-2462.
Cardozo T., Pagano M. (2004) The SCF ubiquitin ligase: insights into a molecular machine. Nat Rev Mol Cell Biol5(9): 739-51.
Clark R.S., Bayir H., Chu C.T., Alber S.M., Kochanek P.M., Watkins S.C. (2008) Autophagy is increased in mice after traumatic brain injury and is detectable in human brain after trauma and critical illness. Autophagy 4: 88-90.
Conforti L., Wilbrey A., Morreale G., Janeckova L., Beirowski B., Adalbert R., Mazzola F., Di Stefano M., Hartley R., Babetto E., Smith T., Gilley J., Billington R.A., Genazzani A.A., Ribchester R.R., Magni G., Coleman M. (2009) Wld S protein requires Nmnat activity and a short N-terminal sequence to protect axons in mice. J Cell Biol 184:491–500
Dahlmann B. (2007) Role of proteasomes in disease.BMC Biochem8 (Suppl 1): S3. Daniel J.A., Grant P.A. (2007) Multi-tasking on chromatin with the SAGA
coactivator complexes. Mutat Res618 :135-48
Dash P.K., Zhao J., Hergenroeder G., Moore A.N. (2010) Biomarker for the diagnosis, prognosis, and evaluation of treatment efficacy for traumatic brain injury. Neurotherapeutics 7:100-114.
Decressac M., Ulusoy A., Mattsson B., Georgievska B., Romero-Ramos M., Kirik D., Björklund A. (2011) GDNF fails to exert neuropro- tection in a rat {alpha}-synuclein model of Parkinson’s disease. Brain 134:2302–2311 Deng P.Y., Lei S. (2007) Long-term depression in identified stellate neurons of
juvenile rat entorhinal cortex. J Neurophysiol97: 727-37.
Donat C.K., Schuhmann M.U., Voigt C., Nieber K., Deuther-Conrad W., Brust P. (2008) Time-dependent alterations of cholinergic markers after experimental traumatic brain injury. Brain Res 1246: 167-177.
Donato R. (1999) Function roles of S100β proteins, calcium binding proteins of the EF-hand type. Biochim Biophys Acta 1450:234-241.
Falzone T.L., Stokin G.B., Lillo C., Rodrigues E.M., Westerman E.L., Williams D.S., Goldstein L.S.B. (2009) Axonal stress kinase activa- tion and tau misbehavior induced by kinesin-1 transport defects. J Neurosci 29:5758– 5767
Faul M., Xu L., Wald M.M., Coronado V.G. (2010) Traumatic Brain Injury in the United States: Emergency Department Visits, Hospitalizations and Deaths 2002–2006. Atlanta (GA): Centers for Disease Control and Prevention, National Center for Injury Prevention and Control.
Finkelstein E., Corso P., Miller T. and Associates. (2006) The Incidence and Economic Burden of Injuries in the United States. New York (NY): Oxford University Press.
George E.B., Glass J.D., Griffin J.W. (1995) Axotomy-induced axonal degeneration influx through ion-specific channels. J Neurosci 75:6445– 6452
Gilley J., Coleman M.P. (2010) Endogenous Nmnat2 is an essential survival factor for maintenance of healthy axons. PLoS Biol 8: e1000300
Gong B. (2006) Ubiquitin hydrolase Uch-L1 rescues beta-amyloid- induced decreases in synaptic function and contextual memory. Cell 126: 775-88. Gong B., Leznik E. (2007) The role of ubiquitin C-terminal hydrolase L1 in
Goodacre S. (2008) Hospital admissions with head injury following publication of NICE guidance. Emerg Med J 25:556-557.
Greenberg M.S., ed (2010) Handbook of neurosurgery, 7th
Hafezparast M. (2003) Mutations in dynein link motor neuron degen- eration to defects in retrograde transport. Science 300:808–812
ed. New York: Thieme.
Hegde A.N. (2004) Ubiquitin-proteasome-mediated local protein degradation and synaptic plasticity. Prog Neurobiol73: 311-57.
Hatakeyama S., Yada M., Matsumoto M., Ishida N., Nakayama K.I. (2001) U box proteins as a new family of ubiquitin-protein ligases. J Biol Chem 276:33111–33120
Hu B.R., Liu C.L., Ouyang Y., Blomgren K., Siesjo B.K. (2000) Involvement of caspase-3 in cell death after hypoxia-ischemia declines during brain maturation. J Cereb Blood Flow Metab 20:1294-1300.
Hyder A.A., Wunderlich C.A., Puvanachandra P., Gururaj G., Kobusingye O.C. (2007) The impact of traumatic brain injuries: a global perspective. NeuroRehabilitation 22:341-353
Jackson P., Thompson R.J. (1981) The demonstration of new human brain-specific proteins by high-resolution-two dimensional polyacrylamide gel electrophoresis. J Neurol Sci 49:429-438.
Kahle P.J. (2000) Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha -synuclein in human and transgenic mouse brain. J Neurosci20: p. 6365-73.
Kanazawa T., Uchihara T., Takahashi A., Nakamura A., Orimo S., Mizusawa H. (2008) Three-layered structure shared between Lewy bodies and Lewy neurites—three-dimensional reconstruction of triple-labeled sections. Brain Pathol 18:415–422
Keller J.N., Huang F.F., Zhu H., Yu J., Ho Y.S., Kindy T.S. (2000) Oxidative stress-associated impairment of proteasome activity during ischemia-reperfusion injury. J Cereb Blood Flow Metab20 :1467-1473.
Kelley B.J., Farkas O., Lifshitz J., Povlishock J.T. (2006) Traumatic axonal injury in the perisomatic domain triggers ultrarapid secondary axotomy and Wallerian degeneration. Exp Neurol 198: 350-360.
Kennedy R.D., D'Andrea A.D. (2005), The Fanconi Anemia/BRCA pathway: new faces in the crowd. Genes Dev.19: 2925- 40.
Kerschensteiner M., Schwab M.E., Lichtman J.W., Misgeld T. (2005) In vivo imaging of axonal degeneration and regeneration in the injured spinal cord. Nat Med 11:572–577
Kilinc D., Gallo G., Barbee K. (2009) Mechanical membrane injury induces axonal beading through localized activation of calpain. Exp Neurol 219:553–561 Knöferle J., Koch J.C., Ostendorf T., Michel U., Planchamp V., Vutova P., Tönges
L., Stadelmann C., Brück W., Bähr M., Lingor P. (2010) Mechanisms of acute axonal degeneration in the optic nerve in vivo. Proc Natl Acad Sci USA 107:6064–6069
Kobeissy F.H., Sadasivan S., Oli M.W., Robinson G., Larner S.F., Zhang Z., Hayes R.L., Wang K.K. (2008) Neuroproteomics and systems biology-based discovery of protein biomarkers for traumatic brain injury and clinical validation. Proteomics Clin Appl2:1467–1483
Kobori N., Hu B., Dash P.K. (2011) Altered adrenergic receptor signaling following traumatic brain injury contributes to working memory dysfunction. Neuroscience 172: 293-302.
Koch J.C., Knöferle J., Tönges L., Ostendorf T., Bähr M., Lingor P. (2010) Acute axonal degeneration in vivo is attenuated by inhibition of autophagy in a calcium-dependent manner. Autophagy (in press)
Kochanek P.M., Berger R.P., Bayir H., Wagner A.K., Jenkins L.W., Clark R.S. (2008) Biomarker of primary and evolving damage in traumatic and ischemic brain injury: diagnosis, prognosis, probing mechanism, and therapeutic decision maker. Curr Opin Crit Care 43:267-270.
Koegl M. (1999) A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly. Cell96: 635-44.
Komada M. (2008) Controlling receptor downregulation by ubiquitination and deubiquitination. Curr Drug Discov Technol5 : 78-84.
Kuo C.T. (2006) Identification of E2/E3 ubiquitinating enzymes and caspase activity regulating Drosophila sensory neuron dendrite pruning.Neuron 51: 283-90.
Larsen C.N., Krantz B.A., Wilkinson K.D. (1998) Substrate specificity of deubiquitinating enzymes: ubiquitin C-terminal hydrolases. Biochemistry37: 3358-68.
Leroy E. (1998) The ubiquitin pathway in Parkinson's disease. Nature 395: 451-2. Levy M.L., Ozgur B.M., Berry C., Aryan H.E., Apuzzo M.L. (2004) Birth and
evolution of the football helmet. Neurosurgery 55:656-661.
Lin J.W., Lin C.M., Tsai J.T., Hung K.S., Hung C.C., Chiu W.T. (2008) Neurotrauma research in Taiwan. Acta Neurochir Suppl 101:113-117. Lincoln S., Vaughan J., Wood N., et. al. (1999) Low frequency of pathogenic
mutations in the ubiquitin carboxy-terminal hydrolase gene in familial Parkinson’s disease. Neuroreport 10:427-429.
Lingor P.,Koch J.C., Tönges L., Bähr M. (2012) Axonal degeneration as a
therapeutic target in the CNS.
Cell Tissue Res
349:289–311Liu Y. (2002) The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility. Cell111: 209-18.
Lunn E.R., Perry V.H., Brown M.C., Rosen H., Gordon S. (1989) Absence of Wallerian degeneration does not hinder regeneration in peripheral nerve. Eur J Neurosci 1:27–33
Lwangsa S.K., Lemeshow. (1998) Sample size determination in health studies, a practical manual version 2.00. World Health Organization.
MacDonald J.M., Beach M.G., Porpiglia E., Sheehan A.E., Watts R.J., Freeman M.R. (2006) The Drosophila cell corpse engulfment receptor Draper mediates glial clearance of severed axons. Neuron 50:869–881
Malinow R. (2003) AMPA receptor trafficking and long-term pot entiation.Philos Trans R Soc Lond B Biol Sci358: 707-14.
McIntosh T.K., Smith D.H., Meaney D.F., Kotapka M.J., Gennarelli T.A., Graham D.I. (1996) Neuropathological sequelae of traumatic brain injury: relationship to neurochemical and biomechanical mecha- nisms. Lab Invest 74:315–342
Menon D.K. (2009) Unique challenges in clinical trials in traumatic brain injury. Crit Care Med 37:S129-135.
Meythaler J.M., Peduzzi J.D., Eleftheriou E., Novack T.A. (2001) Current concepts: diffuse axonal injury-associated traumatic brain injury. Arch Phys Med Rehabil 82:1461–1471
Mondello S., Linnet A., Buki A., et. al. (2012) Clinical Utility of Serum Levels of Ubiquitin C-Terminal Hydrolase as a Biomarker for Severe Traumatic Brain Injury. Neurosurgery 70:666-675.
Morfini G.A., Burns M., Binder L.I., Kanaan N.M., LaPointe N., Bosco D.A., Brown R.H., Brown H., Tiwari A., Hayward L., Edgar J., Nave K-A., Garberrn J., Atagi Y., Song Y., Pigino G., Brady S.T. (2009) Axonal transport defects in neurodegenerative diseases. J Neuro- sci 29:12776– 12786
Nath S., Goodwin J., Engelborghs Y., Pountney D.L. (2011) Raised calcium promotes α-synuclein aggregate formation. Mol Cell Neurosci 46:516–526 Nijman S.M. (2005) A genomic and functional inventory of deubiquitinating
enzymes.Cell 123: 773-86.
Nikić I., Merkler D., Sorbara C., Brinkoetter M., Kreutzfeldt M., Bareyre F.M., Brück W., Bishop D., Misgeld T., Kerschensteiner M. (2011) A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat Med 17:495–499
Nikolaeva M.A., Mukherjee B., Stys P.K. (2005) Na+-dependent sources of intra-axonal Ca2+ release in rat optic nerve during in vitro chemical ischemia. J Neurosci 25:9960–9967
Nirula R., Mock C.N., Nathens A.B., Grossman D.C. (2004) The new car assessment program: does it predict the reality safety of vehicles in actual crashes? J Trauma 57:779-786.
Osaka H. (2003) Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron. Hum Mol Genet 12: 1945-58.
Ouardouz M., Nikolaeva Ma., Coderre E., Zamponi G.W., McRory J.E., Trapp B.D., Yin X., Wang W., Woulfe J., Stys P.K. (2003) Depolarization-induced Ca2+ release in ischemic spinal cord white matter involves L-type Ca2+ channel activation of ryano- dine receptors. Neuron 40:53–63
Pelinka L.E., Kroepfl A., Leixnering M., Buchinger W., Raabe A., Redl H. (2004) GFAP versus S100β in serum after traumatic brain injury: relationship to brain damage and outcome. J Neurotrauma 24: 1793-1801.
Pettus E.H., Christman C.W., Giebel M.L., Povlishock J.T. (1994) Trau- matically induced altered membrane permeability: its relationship to traumatically induced reactive axonal change. J Neurotrauma 11:507–522
Pettus E.H., Povlishock J.T. (1996) Characterization of a distinct set of intra- axonal ultrastructural changes associated with traumatically induced alteration in axolemmal permeability. Brain Res 722:1–11
Pickart C.M. (2004) Back to the future with ubiquitin. Cell116:181-90.
Pickart C.M., Rose I.A. (1985) Ubiquitin carboxyl-terminal hydrolase acts on ubiquitin carboxyl-terminal amides. J Biol Chem260 :7903-10.
Piotrowski J. (1997) Inhibition of the 26 S proteasome by polyubiquitin chains synthesized to have defined lengths. J Biol Chem272: 23712-21.
Raff M.C., Whitmore A.V., Finn J.T. (2002) Axonal self-destruction and neurodegeneration. Science 296:868–871
Ravikumar B., Acevedo-Arozena A., Imarisio S., Berger Z., Vacher C., O’Kane C.J., Brown S.D.M., Rubinsztein D.C. (2005) Dynein muta- tions impair autophagic clearance of aggregate-prone proteins. Nat Genet 37:771–776 Reilly P. (2007) The impact of neurotrauma on society: an international
perspective. Prog Brain Res 161:3-9.
Reinert M.M., Bullock R. (1999) Clinical trials in head injury. Neurol Res 21:330-338
Robicsek G.M., Gabrielli S.A., Robertson C.S., Wang K.K., and Hayes R.L. (2008) Use of biomarkers for diagnosis and management of traumatic brain injury. Expert Opin. Med Diagn 28: 1–9.
Ross C.A., Poirier M.A. (2004) Protein aggregation and neurodegenerative disease. Nat Med10 (Suppl): S10-7.
Ross S.A., Cunningham R.T., Johnston C.F., Rowlands B.J. (1996) Neuron specific enolase as an aid to outcome prediction in head injury. Br J Neurosurg 10:471-476
Rubinsztein D.C. (2006) The roles of intracellular protein-degradation pathways in neurodegeneration. Nature443: 780-6.
Sasaki Y., Vohra B.P.S., Lund F.E., Milbrandt J. (2009b) Nicotinamide mononucleotide adenylyl transferase-mediated axonal protection requires enzymatic activity but not increased levels of neuronal nicotinamide adenine dinucleotide. J Neurosci 29:5525–5535
Saatman K.E., Creed J., Raghupathi R. (2010) Calpain as a therapeutic target in traumatic brain injury. Neurotherapeutics 7:31–42
Schmidt M, et. al. (2005) Proteasome-associated proteins: regulation of a proteolytic machine. Biol Chem386: 725-37.
Setsuie R. (2007) Dopaminergic neuronal loss in transgenic mice expressing the Parkinson's disease-associated UCH-L1 I93M mutant. Neurochem Int 50: p. 119-29.
Sidaros A., Skimminge A., Liptrot M.G., Sidaros K., Engberg A.W., Herning M., Paulson O.B., Jernigan T.L., Rostrup E. (2009) Long-term global and regional brain volume changes following severe traumatic brain injury: a longitudinal study with clinical correlates. Neuroimage 44: 1-8.
Siebert H., Kahle P.J., Kramer M.L., Isik T., Schlüter O.M., Schulz- Schaeffer W.J., Brück W. (2010) Over-expression of alpha- synuclein in the nervous system enhances axonal degeneration after peripheral nerve lesion in a transgenic mouse strain. J Neuro- chem 114:1007–1018
Sievers C., Platt N., Perry V.H., Coleman M.P., Conforti L. (2003) Neurites undergoing Wallerian degeneration show an apoptotic-like pro- cess with annexin V positive staining and loss of mitochondrial membrane potential. Neurosci Res 46:161–169
Song L., Rape M. (2008) Reverse the curse--the role of deubiquitination in cell cycle control. Curr Opin Cell Biol20 :156-63.
Staal J.A., Dickson T.C., Gasperini R., Liu Y., Foa L., Vickers J.C. (2010) Initial calcium release from intracellular stores followed by calcium dysregulation is linked to secondary axotomy following transient axonal stretch injury. J Neurochem 112:1147–1155
Stirling D.P., Stys P.K. (2010) Mechanisms of axonal injury: internodal nanocomplexes and calcium deregulation. Trends Mol Med 16:160–170 Tang-Schomer M.D., Patel A.R., Baas P.W., Smith D.H. (2010) Mechanical
breaking of microtubules in axons during dynamic stretch injury underlies delayed elasticity, microtubule disassembly, and axon degeneration. FASEB J 24:1401–1410
Teasdale G., Jennet B. (1974) Assessment of coma and impaired consciousness : A practical scale. Lancet 2: 81-84
Thurman D.J., Alverson C., Dunn K.A., Guerrero J., Sniezek J.E. (1999) Traumatic brain injury in the United States: A public health persective. J Head Trauma Rehabil 14:602-615.
Tongaonkar P., Chen L., Lambertson D., Ko B., Madura K. (2000) Evidence for an interaction between ubiquitin-conjugating enzymes and the 26S proteasome. Mol Cell Biol. 20:4691-4698.
Touma E., Kato S., Fukui K., Koike T. (2007) Calpain-mediated cleavage of collapsin response mediator protein (CRMP)-2 during neurite degeneration in mice. Eur J Neurosci 26:3368–3381
Trivedi M.A., Ward M.A., Hess T.M., Gale S.D., Dempsey R.J., Rowley H.A., Johnson S.C. (2007) Longitudinal changes in global brain volume between 79 and 409 days after traumatic brain injury: relationship with duration of coma. J Neurotrauma 24: 766- 771.
Upadhya S.C., Hegde. (2005), Ubiquitin-proteasome pathway components as therapeutic targets for CNS maladies.Curr Pharm Des11: 3807-28.
Utton M.A., Noble W.J., Hill J.E., Anderton B.H., Hanger D.P. (2005) Molecular motors implicated in the axonal transport of tau and alpha-synuclein. J Cell Sci 118:4645–4654
Veeranna A., Kaji T., Boland B., Odrljin T., Mohan P., Basavarajappa B.S., Peterhoff C., Cataldo A., Rudnicki A., Amin N., Li B.S., Pant H.C., Hungund B.L., Arancio O., Nixon R.A. (2004) Calpain mediates calcium-induced activation of the erk1,2 MAPK pathway and cytoskeletal phosphorylation in neurons: relevance to Alzheimer’s disease. Am J Pathol 165:795–805
Von Coelln R. (2004) Loss of locus coeruleus neurons and reduced startle in parkin null mice.Proc Natl Acad Sci U S A101: 10744-9.
Vosler P.S., Brennan C.S., Chen J. (2008) Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration. Mol Neu- robiol 38:78–100 Wang K.K., Ottens A.K., Lie M.C., et. al. (2005) Proteomic identification of
biomarker of traumatic brain injury. Expert Rev Proteomics 2:603-604. Weston C.R., Davis R.J. (2007) The JNK signal transduction pathway. Curr Opin
Cell Biol 19:142–149
Whitmore A.V., Lindsten T., Raff M.C., Thompson C.B. (2003) The proa-poptotic proteins Bax and Bak are not involved in Wallerian degeneration. Cell Death Differ 10:260–261
Wilkinson K.D. (1989) The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. Science246: 670-3.
Yahata N., Yuasa S., Araki T. (2009) Nicotinamide mononucleotide adenylyltransferase expression in mitochondrial matrix delays Wallerian degeneration. J Neurosci 29:6276–6284
Yamazaki Y., Yada K., Morii S., Kitahara T., Ohwada T. (1995) Diagnostic significance of serum neuron-specific enolase and myelin basic protein assay in patients with acute head injury. Surg Neurol 43:267-270.
Yao T., Cohen R.E. (2002) A cryptic protease couples deubiquitination and degradation by the proteasome. Nature 419:403-7.
Yoshimura K., Ueno M., Lee S., Nakamura Y., Sato A., Yoshimura K., Kishima H., Yoshimine T., Yamashimta T. (2011) C-Jun N-terminal kinase induces axonal degeneration and limits motor recovery after spinal cord injury in mice. Neurosci Res 71:266–277
Zetterberg M., Sjolander A., von Otter M., Palmer M.S., Landgren S., Minthon L., et. al. (2010). Ubiquitin carboxy-terminal hydrolase L1 (UCHL1) S18Y polymorphism in Alzheimer’s disease.Molecular Neurodegeneration5:11 Zhai Q., Wang J., Kim A., Liu Q., Watts R., Hoopfer E., Mitchison T., Luo L., He
Z. (2003) Involvement of the ubiquitin-proteasome system in the early stages of Wallerian degeneration. Neuron 39:217–225
Zhang L., Yang K.H., King A.I. (2004) A proposed injury threshold for mild traumatic brain injury. J Biomech Eng 126: 226-236.
Zhao C., Takita J., Tanaka Y., Setou M., Nakagawa T., Takeda S., Yang H.W., Terada S., Nakata T., Takei Y., Saito M., Tsuji S., Hayashi Y., Hirokawa N. (2001) Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell 105:587–597
Ziebell J.M., MorgKossmann M.C. (2010) Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury. Neurotherapeutics 7: 22-30
